Business Segment Information (Tables)

9 Months Ended

Sep. 26, 2015

Business Segments

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information
				Three Months Ended						Nine Months Ended
			September 26,			September 27,			September 26,			September 27,
(In millions)				2015			2014			2015			2014
Revenues
	Life Sciences Solutions			$	1,080.4		$	1,071.9		$	3,229.6		$	3,010.5
	Analytical Instruments				778.5			786.5			2,282.9			2,349.8
	Specialty Diagnostics				776.9			811.8			2,379.2			2,480.6
	Laboratory Products and Services				1,638.2			1,628.7			4,844.9			4,918.6
	Eliminations				(150.8)			(127.5)			(423.7)			(362.7)
		Consolidated revenues			4,123.2			4,171.4			12,312.9			12,396.8
Segment Income (a)
	Life Sciences Solutions				332.7			306.3			954.9			850.0
	Analytical Instruments				146.5			137.8			407.8			399.1
	Specialty Diagnostics				204.9			224.3			646.2			681.7
	Laboratory Products and Services				249.6			246.6			731.7			738.3
		Subtotal reportable segments (a)			933.7			915.0			2,740.6			2,669.1
	Cost of revenues charges				(0.8)			(2.1)			(2.5)			(326.7)
	Selling, general and administrative charges, net				(24.6)			(20.3)			(35.4)			(118.0)
	Restructuring and other (costs) income, net				(15.5)			110.6			(67.9)			631.9
	Amortization of acquisition-related intangible assets				(329.9)			(362.9)			(988.8)			(992.4)
		Consolidated operating income			562.9			640.3			1,646.0			1,863.9
	Other expense, net (b)				(94.8)			(101.1)			(292.3)			(313.8)
	Income from continuing operations before income taxes			$	468.1		$	539.2		$	1,353.7		$	1,550.1
Depreciation
	Life Sciences Solutions			$	38.4		$	37.1		$	106.7		$	97.4
	Analytical Instruments				9.9			9.4			28.6			29.0
	Specialty Diagnostics				18.8			19.4			54.6			57.4
	Laboratory Products and Services				30.7			26.9			85.0			79.9
		Consolidated depreciation		$	97.8		$	92.8		$	274.9		$	263.7
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information
				Three Months Ended						Nine Months Ended
			September 26,			September 27,			September 26,			September 27,
(In millions)				2015			2014			2015			2014
Revenues
	Life Sciences Solutions			$	1,080.4		$	1,071.9		$	3,229.6		$	3,010.5
	Analytical Instruments				778.5			786.5			2,282.9			2,349.8
	Specialty Diagnostics				776.9			811.8			2,379.2			2,480.6
	Laboratory Products and Services				1,638.2			1,628.7			4,844.9			4,918.6
	Eliminations				(150.8)			(127.5)			(423.7)			(362.7)
		Consolidated revenues			4,123.2			4,171.4			12,312.9			12,396.8
Segment Income (a)
	Life Sciences Solutions				332.7			306.3			954.9			850.0
	Analytical Instruments				146.5			137.8			407.8			399.1
	Specialty Diagnostics				204.9			224.3			646.2			681.7
	Laboratory Products and Services				249.6			246.6			731.7			738.3
		Subtotal reportable segments (a)			933.7			915.0			2,740.6			2,669.1
	Cost of revenues charges				(0.8)			(2.1)			(2.5)			(326.7)
	Selling, general and administrative charges, net				(24.6)			(20.3)			(35.4)			(118.0)
	Restructuring and other (costs) income, net				(15.5)			110.6			(67.9)			631.9
	Amortization of acquisition-related intangible assets				(329.9)			(362.9)			(988.8)			(992.4)
		Consolidated operating income			562.9			640.3			1,646.0			1,863.9
	Other expense, net (b)				(94.8)			(101.1)			(292.3)			(313.8)
	Income from continuing operations before income taxes			$	468.1		$	539.2		$	1,353.7		$	1,550.1
Depreciation
	Life Sciences Solutions			$	38.4		$	37.1		$	106.7		$	97.4
	Analytical Instruments				9.9			9.4			28.6			29.0
	Specialty Diagnostics				18.8			19.4			54.6			57.4
	Laboratory Products and Services				30.7			26.9			85.0			79.9
		Consolidated depreciation		$	97.8		$	92.8		$	274.9		$	263.7
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.